Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 15;90(5):504-507.
doi: 10.1097/QAI.0000000000003010.

Brief Report: Previous Preexposure Prophylaxis Use Among Men Who Have Sex With Men Newly Diagnosed With HIV Infection in King County, WA

Chase A Cannon  1 , Meena S Ramchandani  1 , Susan Buskin  2 , Julia Dombrowski  1   2   3 , Matthew R Golden  1   2   3
Affiliations

Brief Report: Previous Preexposure Prophylaxis Use Among Men Who Have Sex With Men Newly Diagnosed With HIV Infection in King County, WA

Chase A Cannon et al. J Acquir Immune Defic Syndr. .

Abstract

Background: Preexposure prophylaxis (PrEP) discontinuations are common and are associated with subsequent HIV acquisition. The population-level impact of PrEP discontinuations is unknown.

Methods: Public health staff routinely asked men who have sex with men (MSM) with newly diagnosed HIV infection about their history of PrEP use as part of partner notification interviews in King County, WA, from 2013 to 2021. We assessed trends in the proportion of MSM who ever took PrEP and described reasons for PrEP discontinuation.

Results: A total of 1098 MSM were newly diagnosed with HIV during the study period; of whom, 797 (73%) were interviewed, and 722 responded to questions about their history of PrEP use. Ninety-four (13%) reported ever taking PrEP. The proportion of MSM who ever used PrEP before HIV diagnosis increased from 2.3% in 2014 to 26.6% in 2020-2021 ( P < 0.001 for trend). The median time from PrEP discontinuation to HIV diagnosis was 152 days, and median duration on PrEP was 214 days. Common reasons for stopping PrEP included self-assessment as being at low risk for HIV, side effects, and insurance issues. Nineteen men were on PrEP at the time of HIV diagnosis; mutations conferring emtricitabine/tenofovir resistance were identified in 8 (53%) of 15 men with available genotype data.

Conclusion: More than 25% of MSM with newly diagnosed HIV from 2020 to 2021 had ever used PrEP. More than 50% who discontinued PrEP were diagnosed <6 months after stopping. Strategies to preempt PrEP discontinuations, enhance retention, and facilitate resumption of PrEP are critical to decrease new HIV diagnoses.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: Dr. Ramchandani hold stocks in Gilead Sciences, Inc. and Merck & Co.

Figures

Figure 1:
Figure 1:
Number of New HIV Diagnoses Among MSM in King County, Washington by PrEP Use Status, 2013–2021 Abbreviations: MSM (men who have sex with men), PrEP (pre-exposure prophylaxis) Note: Data span from October 2013 to August 2021. Clustered bar graphs use leftward Y-axis scale and line graph uses rightward Y-axis scale.
See this image and copyright information in PMC

References

    1. Chou R, Evans C, Hoverman A, et al. Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2019;321(22):2214. doi:10.1001/jama.2019.2591 - DOI - PubMed
    1. Sullivan PS, Mouhanna F, Mera R, et al. Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions. Ann Epidemiol. 2020;44:16–30. doi:10.1016/j.annepidem.2020.01.004 - DOI - PubMed
    1. HIV/AIDS Epidemiology Unit, Public Health – Seattle & King County and the Infectious Disease Assessment Unit, Washington State Department of Health. HIV/AIDS Epidemiology Report 2020. 2020;89:116.
    1. Pagkas-Bather J, Khosropour CM, Golden MR, Thibault C, Dombrowski JC. Population-Level Effectiveness of HIV Pre-exposure Prophylaxis Among MSM and Transgender Persons With Bacterial Sexually Transmitted Infections. J Acquir Immune Defic Syndr. 2021;87(2):769–775. doi:10.1097/QAI.0000000000002646 - DOI - PMC - PubMed
    1. Chan PA, Mena L, Patel R, et al. Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities. J Int AIDS Soc. 2016;19(1):20903. doi:10.7448/IAS.19.1.20903 - DOI - PMC - PubMed

Publication types